Adcock Ingram
 |
|
| Public | |
| Traded as | JSE: AIP |
| Industry | Health Care, Pharmaceuticals |
| Headquarters | Johannesburg, South Africa |
|
Area served
|
South Africa and Selected Emerging Markets (southern Africa, Ghana, India) |
|
Key people
|
Andy Hall (CEO) |
| Products | Pharmaceuticals and Health Care |
| Revenue | R10.5 Billion (FY 2015) |
|
Number of employees
|
2374 |
| Subsidiaries | Adcock Ingram Critical Care, Adcock Ingram pharmaceuticals |
| Website | www.adcock.co.za |
Andy Hall (CEO)
Dorette Neethling (CFO Acting)
Adcock Ingram is a South African pharmaceutical company listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market. Adcock Ingram has four commercial divisions: Consumer, OTC, Prescription and Critical Care. Its market capitalisation is about R9 billion.
Adcock Ingram is a level 4 B-BBEE contributor.
Adcock Ingram first started out as a pharmacy in Krugersdorp trading under the name EJ Adcock Pharmacy in 1891. In the early 1900s, Hyme Tannenbaum was apprenticed to then owner, Jack Blair. Hyme's brothers Jack, Len and Archie soon followed him into the pharmacy, which they eventually bought. Beginning with this one small pharmacy, the Tannenbaum brothers built a cross-country chain of retail pharmacies, a pharmaceutical and toiletry manufacturing giant and a highly respected South African success story. Adcock Ingram was first listed on the in 1950. The company was sold to Tiger Brands in 1999 for R3.4 billion. In August 2008 Adcock Ingram relisted on the JSE with 172.6 million ordinary issued shares at a price of R33.50 each.
...
Wikipedia